4//SEC Filing
Fleming Harold Edward 4
Accession 0001209191-22-036036
CIK 0001674416other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:36 PM ET
Size
9.6 KB
Accession
0001209191-22-036036
Insider Transaction Report
Form 4
Fleming Harold Edward
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 totalExercise: $71.70Exp: 2032-06-09→ Common Shares (12,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders.
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001857250
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:36 PM ET
- Size
- 9.6 KB